1. Home
  2. MYSZ vs SNPX Comparison

MYSZ vs SNPX Comparison

Compare MYSZ & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYSZ
  • SNPX
  • Stock Information
  • Founded
  • MYSZ 1999
  • SNPX 2012
  • Country
  • MYSZ Israel
  • SNPX United States
  • Employees
  • MYSZ N/A
  • SNPX N/A
  • Industry
  • MYSZ Computer Software: Prepackaged Software
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • MYSZ Technology
  • SNPX Health Care
  • Exchange
  • MYSZ Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • MYSZ 2.9M
  • SNPX 3.1M
  • IPO Year
  • MYSZ N/A
  • SNPX N/A
  • Fundamental
  • Price
  • MYSZ $1.36
  • SNPX $2.33
  • Analyst Decision
  • MYSZ Strong Buy
  • SNPX Strong Buy
  • Analyst Count
  • MYSZ 1
  • SNPX 1
  • Target Price
  • MYSZ $3.00
  • SNPX $14.00
  • AVG Volume (30 Days)
  • MYSZ 3.7M
  • SNPX 11.5K
  • Earning Date
  • MYSZ 05-14-2025
  • SNPX 05-14-2025
  • Dividend Yield
  • MYSZ N/A
  • SNPX N/A
  • EPS Growth
  • MYSZ N/A
  • SNPX N/A
  • EPS
  • MYSZ N/A
  • SNPX N/A
  • Revenue
  • MYSZ $8,257,000.00
  • SNPX N/A
  • Revenue This Year
  • MYSZ $29.71
  • SNPX N/A
  • Revenue Next Year
  • MYSZ N/A
  • SNPX N/A
  • P/E Ratio
  • MYSZ N/A
  • SNPX N/A
  • Revenue Growth
  • MYSZ 18.02
  • SNPX N/A
  • 52 Week Low
  • MYSZ $1.01
  • SNPX $1.84
  • 52 Week High
  • MYSZ $9.40
  • SNPX $5.38
  • Technical
  • Relative Strength Index (RSI)
  • MYSZ 48.75
  • SNPX 49.26
  • Support Level
  • MYSZ $1.01
  • SNPX $2.05
  • Resistance Level
  • MYSZ $1.61
  • SNPX $2.21
  • Average True Range (ATR)
  • MYSZ 0.16
  • SNPX 0.18
  • MACD
  • MYSZ 0.03
  • SNPX 0.04
  • Stochastic Oscillator
  • MYSZ 53.97
  • SNPX 79.51

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: